Health ❯Healthcare ❯Pharmaceuticals ❯Weight Loss

GLP-1 Drugs

Diabetes Treatments Market Trends Weight Loss Risk Reduction Drug Safety Weight Management Dieting Culture Chronic Diseases Regulations Patient Safety

Novo Nordisk Ends Hims & Hers Wegovy Partnership and Debuts Obesity Drug in India

The move responds to Hims & Hers' continued distribution of compounded semaglutide despite FDA declarations that shortages were resolved

Weight Management Revolution: GLP-1 Drugs Dominate as Pills Emerge

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials